PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Placebos work -- even without deception

2010-12-23
(Press-News.org) For most of us, the "placebo effect" is synonymous with the power of positive thinking; it works because you believe you're taking a real drug. But a new study rattles this assumption.

Researchers at Harvard Medical School's Osher Research Center and Beth Israel Deaconess Medical Center (BIDMC) have found that placebos work even when administered without the seemingly requisite deception.

The study published on December 22 in PLoS ONE.

Placebos—or dummy pills—are typically used in clinical trials as controls for potential new medications. Even though they contain no active ingredients, patients often respond to them. In fact, data on placebos is so compelling that many American physicians (one study estimates 50 percent) secretly give placebos to unsuspecting patients.

Because such "deception" is ethically questionable, HMS associate professor of medicine Ted Kaptchuk teamed up with colleagues at BIDMC to explore whether or not the power of placebos can be harnessed honestly and respectfully.

To do this, 80 patients suffering from irritable bowel syndrome (IBS) were divided into two groups: one group, the controls, received no treatment, while the other group received a regimen of placebos—honestly described as "like sugar pills"—which they were instructed to take twice daily.

"Not only did we make it absolutely clear that these pills had no active ingredient and were made from inert substances, but we actually had 'placebo' printed on the bottle," says Kaptchuk. "We told the patients that they didn't have to even believe in the placebo effect. Just take the pills."

For a three-week period, the patients were monitored. By the end of the trial, nearly twice as many patients treated with the placebo reported adequate symptom relief as compared to the control group (59 percent vs. 35 percent). Also, on other outcome measures, patients taking the placebo doubled their rates of improvement to a degree roughly equivalent to the effects of the most powerful IBS medications.

"I didn't think it would work," says senior author Anthony Lembo, HMS associate professor of medicine at BIDMC and an expert on IBS. "I felt awkward asking patients to literally take a placebo. But to my surprise, it seemed to work for many of them."

The authors caution that this study is small and limited in scope and simply opens the door to the notion that placebos are effective even for the fully informed patient—a hypothesis that will need to be confirmed in larger trials.

"Nevertheless," says Kaptchuk, "these findings suggest that rather than mere positive thinking, there may be significant benefit to the very performance of medical ritual. I'm excited about studying this further. Placebo may work even if patients know it is a placebo."

INFORMATION:

This study was funded by the National Center for Complementary and Alternative Medicine and Osher Research Center, Harvard Medical School.

Written by David Cameron.

Competing Interests: AJL has worked as a consultant for Ironwood, GSK, Salix, Alkermes, and Ardelyx. These companies have had no relationship to this study. All other authors report no competing interest or appearance of competing interest.

Funding: This study was partially supported by grant K24 AT004095, R01 AT00402-01 and R01AT004662 from National Center for Complementary and Alternative Medicine-NIH and in part from a gift from The Bernard Osher Foundation. The opinions expressed by the authors are their views alone and do not reflect the official views or policy of the National Center for Complementary and Alternative Medicine, National Institutes of Health, Public Health Service or the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Contacts:

BETH ISRAEL DEACONESS MEDICAL CENTER CONTACT
Bonnie Prescott
bprescot@bidmc.harvard.edu
617.667.7306

HARVARD MEDICAL SCHOOL CONTACT
David Cameron
communications@hms.harvard.edu
617.432.0442

Jen Laloup
Public Library of Science
jlaloup@plos.org
415-624-1220

Citation: Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, et al. (2010) Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome. PLoS ONE 5(12): e15591. doi:10.1371/journal.pone.0015591

PLEASE LINK TO THE SCIENTIFIC ARTICLE IN ONLINE VERSIONS OF YOUR REPORT (URL goes live after the embargo ends): http://dx.plos.org/10.1371/journal.pone.0015591

FOR A PRESS-ONLY PREVIEW OF THE FULL ARTICLE, VISIT THE FOLLOWING URL: http://www.plos.org/press/pone-05-12-kaptchuk.pdf

Disclaimer:

This press release refers to an upcoming article in PLoS ONE. The releases have been provided by the article authors and/or journal staff. Any opinions expressed in these are the personal views of the contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.

About PLoS ONE

PLoS ONE is the first journal of primary research from all areas of science to employ a combination of peer review and post-publication rating and commenting, to maximize the impact of every report it publishes. PLoS ONE is published by the Public Library of Science (PLoS), the open-access publisher whose goal is to make the world's scientific and medical literature a public resource.

END



ELSE PRESS RELEASES FROM THIS DATE:

Designer probiotics could reduce obesity

2010-12-23
Specially designed probiotics can modulate the physiology of host fat cells say scientists writing in Microbiology. The findings could lead to specialised probiotics that have a role in the prevention or treatment of conditions such as obesity. Scientists from the Alimentary Pharmabiotic Centre (APC), Cork, University College Cork and Teagasc, in Ireland engineered a strain of Lactobacillus to produce a version of a molecule called conjugated linoleic acid (CLA). When this engineered bacterial strain was fed to mice, the researchers found that the composition of the mice's ...

Scientists reveal how biological activity is regulated in fruit fly and roundworm genomes

2010-12-23
Scientists today published catalogs of the fruit fly and roundworm's functional genomic elements: DNA sequences in the genome that carry the instructions and determine which genes are turned on and off at various times in different cells. Initially sequenced as part of the Human Genome Project, the genomes of the fruit fly, Drosophila melanogaster, and the roundworm, Caenorhabditis elegans, are powerful models for understanding human biology and disease, as many functional genomic elements have been conserved across the vast evolutionary distances separating each organism. ...

Movement and threat of RNA viruses widespread in pollinator community

2010-12-23
Penn State researchers have found that native pollinators, like wild bees and wasps, are infected by the same viral diseases as honey bees and that these viruses are transmitted via pollen. Their research published on December 22nd in PLoS ONE, an online open-access journal for the communication of all peer-reviewed scientific and medical research. This multi-institutional study provides new insights into viral infections in native pollinators, suggesting that viral diseases may be key factors impacting pollinator populations. According to Diana Cox-Foster, co-author ...

Learning to read the genome

Learning to read the genome
2010-12-23
In the past decade researchers have made astonishing progress in the rapid and accurate sequencing of genomes from all realms of life. Yet the listing of chemical base pairs has gotten far ahead of understanding how the information they contain becomes functional. Even the best-understood genomes conceal mysteries. Genetic information carried by DNA and RNA operates together with the patterns and physical organization of chromosomes to produce a working organism. Major advances in understanding these complex relationships are published this week by the "model organism ...

UT Southwestern researchers identify site in brain where leptin may trigger puberty

2010-12-23
DALLAS – Dec. 22, 2010 – UT Southwestern Medical Center researchers have pinpointed a tiny site in the brain where the hormone leptin may help trigger the onset of puberty. The findings in mice indicate that a site within the hypothalamus called the ventral premammillary nucleus, or PMV, is the target where the hormone leptin effectively kick starts puberty in females. Researchers have known that puberty starts when individuals have enough energy stores or fat to meet the demands of reproduction, and that leptin – a hormone produced by fat cells – acts in the brain ...

Brain gene makes a female develop as a male

2010-12-23
Australian scientists have discovered that changes to a gene involved in brain development can lead to testis formation and male genitalia in an otherwise female embryo. Lead Melbourne researcher Professor Andrew Sinclair, of the Murdoch Childrens Research Institute and the University of Melbourne, said the breakthrough would improve diagnosis and clinical management of patients with disorders of sex development (DSD). These conditions occur when the testes or ovaries do not develop properly in the embryo, causing genital abnormalities in one in 4500 babies. The gene, ...

Brain gene a trigger for determining gender

Brain gene a trigger for determining gender
2010-12-23
University of Adelaide researchers are a step closer to unraveling the mysteries of human sexual development, following genetic studies that show male mice can be created without a Y chromosome – through the activation of an ancient brain gene. Males usually have one Y chromosome and one X chromosome, while females have two X chromosomes. A single gene on the Y, called SRY, triggers testes development in the early embryo, and once these begin to form, the rest of the embryo also becomes male. However, Adelaide researchers have discovered a way of creating a male mouse ...

Shouldering family demands and worries bumps up angina risk

2010-12-23
Shouldering family demands and worries seems to increase the risk of angina, the precursor to coronary artery disease, reveals research published online in the Journal of Epidemiology and Community Health. Previous research has indicated that rewarding personal relationships are a boost for heart health, so the authors wanted to know if the reverse might also be true. They tracked the heart health of more than 4,500 randomly selected men and women in their 40s and 50s for six years. None had any heart problems at the start of the study in 1999. In 2006 all participants ...

Complementary medicines can be dangerous for children

2010-12-23
Complementary medicines (CAM) can be dangerous for children and can even prove fatal, if substituted for conventional medicine, indicates an audit of kids' CAM treatment published online in the Archives of Disease in Childhood. But parents often misguidedly think CAM treatments are better for their children because they are "natural" and therefore less likely to have harmful side effects, say the authors. They base their findings on monthly reporting of adverse events associated with CAM to the Australian Paediatric Surveillance Unit between 2001 and 2003. During ...

Teen girls in most deprived areas 5 times as likely to be assaulted

2010-12-23
Teen girls living in the most deprived areas are five times as likely to be assaulted as their affluent male and female peers, reveals research published online in Emergency Medicine Journal. Young men are twice as likely to be a victim of assault as young women, but the link between deprivation and assault is far stronger for their female peers, the study shows. Violence is the third leading cause of death among 15 to 19 year olds and the 14th leading cause of death among 10 to 14 year olds worldwide. In 2007, around 66,000 children and teens in England and Wales were ...

LAST 30 PRESS RELEASES:

Human activity is causing toxic thallium to enter the Baltic sea, according to new study

NREL proof of concept shows path to easier recycling of solar modules

NREL invites robots to help make wind turbine blades

Scent sells – but the right picture titillates both eyes and nose, research finds

Low intensity light to fight the effects of chronic stress

Wildfires in wet African forests have doubled in recent decades

Dietary changes may treat pulmonary hypertension

UTA scientists test for quantum nature of gravity

SCAI announces recipients of 2024 early career research grants

AI can tell if a patient battling cancer needs mental health support

ISSCR announces Hong Kong, SAR as location for its 2025 Annual Meeting

Zoology: First report of wound treatment by a wild animal using a medicinal plant

Longer interval between first colonoscopy with negative findings for colorectal cancer and repeat colonoscopy

Smoking cessation after initial treatment failure with varenicline or nicotine replacement

How the brain’s arousal center helps control visual attention too

Increasing doses of varenicline or nicotine replacement helps persistent smokers quit

Artificial intelligence yields promising results for advancing coronary angiography

Non-fasting pre-procedural strategy for cardiac catheterization significantly improved patient well-being and satisfaction

Gene therapy treatment increasing body’s signal for new blood vessel growth shows promise

Novel score system accurately identifies lesions reducing risk of PCI complications

Women need better treatments for bacterial vaginosis

Webb telescope probably didn’t find life on an exoplanet — yet

Radial arterial access found superior to femoral access in percutaneous coronary intervention

Money on their minds: Health-related costs top older adults’ concerns for people their age, poll finds

To bend the curve of biodiversity loss, nature recovery must be integrated across all sectors

Singapore study identifies immunity threshold for protection against COVID-19 in children

National incidence of heart attacks decline 50% since 2004, yet underrepresented groups remain at highest risk

TAVR is associated with lower in-hospital complications in patients with aortic stenosis and cardiogenic shock compared to SAVR

New studies reveal underrepresentation of women and Hispanic population in the treatment of peripheral artery disease

Empire Discovery Institute receives commercial funding award from the National Multiple Sclerosis Society

[Press-News.org] Placebos work -- even without deception